Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide.
Nu Skin Enterprises Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$41.27|
|52 Week High||US$40.78|
|52 Week Low||US$63.85|
|1 Month Change||-20.31%|
|3 Month Change||-29.14%|
|1 Year Change||-19.24%|
|3 Year Change||-49.76%|
|5 Year Change||-34.80%|
|Change since IPO||43.55%|
Recent News & Updates
|NUS||US Personal Products||US Market|
Return vs Industry: NUS underperformed the US Personal Products industry which returned 52.4% over the past year.
Return vs Market: NUS underperformed the US Market which returned 36.2% over the past year.
Stable Share Price: NUS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: NUS's weekly volatility (5%) has been stable over the past year.
About the Company
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.
Nu Skin Enterprises Fundamentals Summary
|NUS fundamental statistics|
Is NUS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NUS income statement (TTM)|
|Cost of Revenue||US$720.67m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||4.66|
|Net Profit Margin||8.35%|
How did NUS perform over the long term?See historical performance and comparison
3.7%Current Dividend Yield
Is Nu Skin Enterprises undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NUS ($41.27) is trading below our estimate of fair value ($123.51)
Significantly Below Fair Value: NUS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NUS is good value based on its PE Ratio (8.7x) compared to the US Personal Products industry average (16.5x).
PE vs Market: NUS is good value based on its PE Ratio (8.7x) compared to the US market (17.7x).
Price to Earnings Growth Ratio
PEG Ratio: NUS is poor value based on its PEG Ratio (2.1x)
Price to Book Ratio
PB vs Industry: NUS is good value based on its PB Ratio (2.3x) compared to the US Personal Products industry average (2.7x).
How is Nu Skin Enterprises forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NUS's forecast earnings growth (4.1% per year) is above the savings rate (2%).
Earnings vs Market: NUS's earnings (4.1% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: NUS's earnings are forecast to grow, but not significantly.
Revenue vs Market: NUS's revenue (3.5% per year) is forecast to grow slower than the US market (9.8% per year).
High Growth Revenue: NUS's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NUS's Return on Equity is forecast to be high in 3 years time (25.4%)
How has Nu Skin Enterprises performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NUS has high quality earnings.
Growing Profit Margin: NUS's current net profit margins (8.4%) are higher than last year (6.3%).
Past Earnings Growth Analysis
Earnings Trend: NUS's earnings have grown by 7.9% per year over the past 5 years.
Accelerating Growth: NUS's earnings growth over the past year (62.3%) exceeds its 5-year average (7.9% per year).
Earnings vs Industry: NUS earnings growth over the past year (62.3%) exceeded the Personal Products industry 54.7%.
Return on Equity
High ROE: NUS's Return on Equity (25.8%) is considered high.
How is Nu Skin Enterprises's financial position?
Financial Position Analysis
Short Term Liabilities: NUS's short term assets ($961.5M) exceed its short term liabilities ($616.3M).
Long Term Liabilities: NUS's short term assets ($961.5M) exceed its long term liabilities ($515.9M).
Debt to Equity History and Analysis
Debt Level: NUS's debt to equity ratio (48%) is considered high.
Reducing Debt: NUS's debt to equity ratio has reduced from 55.2% to 48% over the past 5 years.
Debt Coverage: NUS's debt is well covered by operating cash flow (48.7%).
Interest Coverage: NUS's interest payments on its debt are well covered by EBIT (23.6x coverage).
What is Nu Skin Enterprises's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: NUS's dividend (3.68%) is higher than the bottom 25% of dividend payers in the US market (1.35%).
High Dividend: NUS's dividend (3.68%) is in the top 25% of dividend payers in the US market (3.63%)
Stability and Growth of Payments
Stable Dividend: NUS's dividends per share have been stable in the past 10 years.
Growing Dividend: NUS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (32.4%), NUS's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: NUS's dividends in 3 years are forecast to be well covered by earnings (31.6% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ritch Wood (55 yo)
Mr. Ritch N. Wood has been the Chief Executive Officer of Nu Skin Enterprises, Inc. since March 7, 2017. Mr. Wood served as the Chief Financial Officer at Nu Skin Enterprises Inc. from November 2002 to Mar...
CEO Compensation Analysis
Compensation vs Market: Ritch's total compensation ($USD6.64M) is above average for companies of similar size in the US market ($USD3.68M).
Compensation vs Earnings: Ritch's compensation has increased by more than 20% in the past year.
Experienced Management: NUS's management team is considered experienced (4.5 years average tenure).
Experienced Board: NUS's board of directors are seasoned and experienced ( 10.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Nu Skin Enterprises, Inc.'s employee growth, exchange listings and data sources
- Name: Nu Skin Enterprises, Inc.
- Ticker: NUS
- Exchange: NYSE
- Founded: 1984
- Industry: Personal Products
- Sector: Household
- Market Cap: US$2.053b
- Shares outstanding: 50.13m
- Website: https://www.nuskin.com
Number of Employees
- Nu Skin Enterprises, Inc.
- 75 West Center Street
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/23 22:57|
|End of Day Share Price||2021/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.